LifeMD (LFMD) Stock Forecast, Price Target & Predictions
LFMD Stock Forecast
LifeMD stock forecast is as follows: an average price target of $12.00 (represents a 106.90% upside from LFMD’s last price of $5.80) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
LFMD Price Target
The average price target for LifeMD (LFMD) is $12.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $12.00 to $12.00. This represents a potential 106.90% upside from LFMD's last price of $5.80.
LFMD Analyst Ratings
According to 4 Wall Street analysts, LifeMD's rating consensus is 'Buy'. The analyst rating breakdown for LFMD stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
LifeMD Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 14, 2024 | Kyle Bauser | BTIG | - | - | 158.62% | 106.90% |
| Jun 04, 2024 | Steve Dechert | KeyBanc | - | - | 59.36% | 106.90% |
| Apr 23, 2024 | David Larsen | BTIG | - | - | 40.00% | 141.38% |
The latest LifeMD stock forecast, released on Oct 14, 2024 by Kyle Bauser from BTIG, set a price target of $12.00, which represents a 158.62% increase from the stock price at the time of the forecast ($4.64), and a 106.90% increase from LFMD last price ($5.80).
LifeMD Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $12.00 | $12.67 |
| Last Closing Price | $5.80 | $5.80 | $5.80 |
| Upside/Downside | -100.00% | 106.90% | 118.45% |
In the current month, the average price target of LifeMD stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to LifeMD's last price of $5.80. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 14, 2024 | BTIG | Buy | Buy | Hold |
| Jul 11, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Jun 04, 2024 | KeyBanc | Overweight | Initialise | |
| May 21, 2024 | B. Riley | Buy | Buy | Hold |
| May 09, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Apr 23, 2024 | BTIG | Buy | Buy | Hold |
| Jul 21, 2023 | Cantor Fitzgerald | Overweight | Initialise | |
| May 16, 2022 | BTIG | Buy | Buy | Hold |
LifeMD's last stock rating was published by BTIG on Oct 14, 2024. The company gave LFMD a "Buy" rating, the same as its previous rate.
LifeMD Financial Forecast
LifeMD Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $44.86M | $24.34M | $22.35M | $33.13M | $28.12M | $31.41M | $30.46M | $29.04M | $27.42M | $24.95M | $22.31M | $18.20M | $12.89M |
| Avg Forecast | $73.57M | $72.93M | $69.20M | $67.38M | $68.65M | $65.51M | $62.25M | $58.79M | $57.24M | $53.82M | $48.46M | $42.59M | $41.30M | $38.44M | $35.15M | $30.81M | $33.58M | $31.85M | $31.31M | $31.53M | $27.46M | $25.28M | $21.78M | $18.22M | $13.26M |
| High Forecast | $74.87M | $74.22M | $70.42M | $68.57M | $69.87M | $66.67M | $63.35M | $59.78M | $57.39M | $53.87M | $48.46M | $43.34M | $41.45M | $38.58M | $35.77M | $31.35M | $34.17M | $31.85M | $31.31M | $31.53M | $27.46M | $25.28M | $21.78M | $18.22M | $13.26M |
| Low Forecast | $71.36M | $70.75M | $67.13M | $65.36M | $66.59M | $63.55M | $60.39M | $57.02M | $57.09M | $53.77M | $48.46M | $41.31M | $41.15M | $38.30M | $34.09M | $29.88M | $32.57M | $31.85M | $31.31M | $31.53M | $27.46M | $25.28M | $21.78M | $18.22M | $13.26M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 0.63% | 0.64% | 1.08% | 0.84% | 0.99% | 0.97% | 0.92% | 1.00% | 0.99% | 1.02% | 1.00% | 0.97% |
LifeMD's average Quarter revenue forecast for Mar 24 based on 1 analysts is $42.59M, with a low forecast of $41.31M, and a high forecast of $43.34M. LFMD's average Quarter revenue forecast represents a -5.07% decrease compared to the company's last Quarter revenue of $44.86M (Dec 23).
LifeMD EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-230.81K | $657.22K | $-288.99K | $-1.48M | $-1.92M | $-5.68M | $-12.04M | $-12.58M | $-17.91M | $-12.41M | $-15.63M | $-11.35M | $-31.66M |
| Avg Forecast | $-31.96M | $-31.69M | $-30.07M | $-29.27M | $-29.83M | $-28.46M | $-27.05M | $-25.54M | $-24.87M | $-23.38M | $-21.05M | $-18.50M | $-17.94M | $-16.70M | $-15.27M | $-13.39M | $-14.59M | $-13.12M | $-12.90M | $-10.04M | $-11.31M | $-10.41M | $-8.97M | $-14.74M | $-5.46M |
| High Forecast | $-31.00M | $-30.74M | $-29.16M | $-28.40M | $-28.93M | $-27.61M | $-26.24M | $-24.77M | $-24.80M | $-23.36M | $-21.05M | $-17.95M | $-17.88M | $-16.64M | $-14.81M | $-12.98M | $-14.15M | $-13.12M | $-12.90M | $-8.04M | $-11.31M | $-10.41M | $-8.97M | $-11.80M | $-5.46M |
| Low Forecast | $-32.53M | $-32.25M | $-30.60M | $-29.79M | $-30.35M | $-28.96M | $-27.52M | $-25.97M | $-24.93M | $-23.40M | $-21.05M | $-18.83M | $-18.01M | $-16.76M | $-15.54M | $-13.62M | $-14.85M | $-13.12M | $-12.90M | $-12.05M | $-11.31M | $-10.41M | $-8.97M | $-17.69M | $-5.46M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.01% | -0.04% | 0.02% | 0.11% | 0.13% | 0.43% | 0.93% | 1.25% | 1.58% | 1.19% | 1.74% | 0.77% | 5.80% |
3 analysts predict LFMD's average Quarter EBITDA for Dec 23 to be $-17.94M, with a high of $-17.88M and a low of $-18.01M. This is -2830.02% lower than LifeMD's previous annual EBITDA (Sep 23) of $657.22K.
LifeMD Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-3.73M | $-6.90M | $-7.51M | $-10.08M | $-11.58M | $-8.44M | $-13.09M | $-13.47M | $-18.01M | $-14.35M | $-16.83M | $-11.60M | $-32.25M |
| Avg Forecast | $3.78M | $3.36M | $3.36M | $3.36M | $2.77M | $210.10K | $-980.48K | $-2.01M | $-2.03M | $-4.97M | $-6.05M | $-6.47M | $-5.88M | $-3.64M | $-3.99M | $-6.72M | $-7.56M | $-8.67M | $-11.56M | $-10.17M | $-15.49M | $-22.92M | $-20.85M | $-15.07M | $-68.14M |
| High Forecast | $3.87M | $3.44M | $3.44M | $3.44M | $2.84M | $214.92K | $-942.24K | $-1.87M | $-1.02M | $-4.78M | $-5.81M | $-6.22M | $-5.04M | $-3.50M | $-3.84M | $-6.46M | $-7.27M | $-8.67M | $-11.56M | $-8.13M | $-15.49M | $-22.92M | $-20.85M | $-12.05M | $-68.14M |
| Low Forecast | $3.63M | $3.23M | $3.23M | $3.23M | $2.67M | $201.91K | $-1.00M | $-2.15M | $-2.71M | $-5.09M | $-6.19M | $-6.62M | $-6.30M | $-3.73M | $-4.08M | $-6.88M | $-7.74M | $-8.67M | $-11.56M | $-12.20M | $-15.49M | $-22.92M | $-20.85M | $-18.08M | $-68.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.63% | 1.89% | 1.88% | 1.50% | 1.53% | 0.97% | 1.13% | 1.32% | 1.16% | 0.63% | 0.81% | 0.77% | 0.47% |
LifeMD's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. LFMD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
LifeMD SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $35.96M | $33.18M | $31.69M | $27.32M | $26.37M | $29.68M | $35.07M | $34.21M | $32.54M | $30.99M | $32.80M | $25.50M | $42.11M |
| Avg Forecast | $92.76M | $91.96M | $87.26M | $84.96M | $86.57M | $82.60M | $78.50M | $74.13M | $72.18M | $67.86M | $61.10M | $53.70M | $52.07M | $48.47M | $44.32M | $38.85M | $42.34M | $40.16M | $39.48M | $24.71M | $34.63M | $31.87M | $27.47M | $22.97M | $16.71M |
| High Forecast | $94.40M | $93.58M | $88.80M | $86.46M | $88.09M | $84.06M | $79.88M | $75.37M | $72.37M | $67.92M | $61.10M | $54.64M | $52.26M | $48.65M | $45.10M | $39.53M | $43.09M | $40.16M | $39.48M | $29.65M | $34.63M | $31.87M | $27.47M | $22.97M | $16.71M |
| Low Forecast | $89.98M | $89.20M | $84.64M | $82.41M | $83.97M | $80.13M | $76.14M | $71.90M | $71.99M | $67.80M | $61.10M | $52.09M | $51.88M | $48.29M | $42.99M | $37.68M | $41.07M | $40.16M | $39.48M | $19.77M | $34.63M | $31.87M | $27.47M | $22.97M | $16.71M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.68% | 0.71% | 0.70% | 0.62% | 0.74% | 0.89% | 1.38% | 0.94% | 0.97% | 1.19% | 1.11% | 2.52% |
LifeMD's average Quarter SG&A projection for Mar 24 is $53.70M, based on 1 Wall Street analysts, with a range of $52.09M to $54.64M. The forecast indicates a 49.31% rise compared to LFMD last annual SG&A of $35.96M (Dec 23).
LifeMD EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.10 | $-0.20 | $-0.23 | $-0.32 | $-0.37 | $-0.27 | $-0.42 | $-0.44 | $-0.67 | $-0.54 | $-0.64 | $-0.47 | $-2.56 |
| Avg Forecast | $0.09 | $0.08 | $0.08 | $0.08 | $0.07 | $0.01 | $-0.02 | $-0.05 | $-0.05 | $-0.12 | $-0.14 | $-0.15 | $-0.14 | $-0.09 | $-0.10 | $-0.16 | $-0.18 | $-0.21 | $-0.28 | $-0.29 | $-0.38 | $-0.56 | $-0.51 | $-0.38 | $-1.65 |
| High Forecast | $0.09 | $0.08 | $0.08 | $0.08 | $0.07 | $0.01 | $-0.02 | $-0.04 | $-0.02 | $-0.11 | $-0.14 | $-0.15 | $-0.12 | $-0.08 | $-0.09 | $-0.15 | $-0.17 | $-0.21 | $-0.28 | $-0.29 | $-0.38 | $-0.56 | $-0.51 | $-0.38 | $-1.65 |
| Low Forecast | $0.09 | $0.08 | $0.08 | $0.08 | $0.06 | - | $-0.02 | $-0.05 | $-0.06 | $-0.12 | $-0.15 | $-0.16 | $-0.15 | $-0.09 | $-0.10 | $-0.16 | $-0.18 | $-0.21 | $-0.28 | $-0.29 | $-0.38 | $-0.56 | $-0.51 | $-0.38 | $-1.65 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.71% | 2.31% | 2.42% | 2.00% | 2.06% | 1.29% | 1.50% | 1.52% | 1.79% | 0.97% | 1.27% | 1.24% | 1.55% |
According to undefined Wall Street analysts, LifeMD's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to LFMD previous annual EPS of $NaN (undefined).